CN113633745A - Traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis - Google Patents
Traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis Download PDFInfo
- Publication number
- CN113633745A CN113633745A CN202111144369.6A CN202111144369A CN113633745A CN 113633745 A CN113633745 A CN 113633745A CN 202111144369 A CN202111144369 A CN 202111144369A CN 113633745 A CN113633745 A CN 113633745A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- treating
- medicine formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
The invention discloses a traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis, which comprises the following raw materials in parts by weight: 15-45 parts of astragalus membranaceus, 15-45 parts of semen coicis, 15-45 parts of salvia miltiorrhiza, 15-45 parts of fried white paeony root, 5-25 parts of codonopsis pilosula, 5-25 parts of poria cocos, 5-25 parts of bighead atractylodes rhizome, 5-25 parts of radix stephaniae tetrandrae, 5-25 parts of cassia twig, 5-25 parts of parasitic loranthus, 4-20 parts of semen brassicae, 4-20 parts of radix clematidis, 2-18 parts of turmeric, 2-10 parts of ground beetle, 2-10 parts of scorpion and 2-10 parts of centipede. The traditional Chinese medicine provided by the invention has definite curative effect, small toxic and side effects and few side effects, treats both principal and secondary aspects of diseases, and has the effects of tonifying qi, activating blood, eliminating phlegm and eliminating arthralgia. In addition, the medicine can be prepared into various dosage forms for convenient taking.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis.
Background
Rheumatoid Arthritis (RA) is a systemic autoimmune disease mainly based on non-infectious inflammation of joints and tissues around the joints, the main pathology of which is changed into chronic inflammation of joint synovium, for example, the condition is improperly controlled, within 2 years of symptoms, 50-90% of patients have radiologic changes of joint damage, finally resulting in joint deformity, joint rigidity and function loss, resulting in disability of different degrees; it belongs to the category of arthralgia syndrome in traditional Chinese medicine, and has pathogenesis of principal deficiency, secondary excess, phlegm stasis and obstruction. RA patients not only suffer from the physiological pains of joint swelling, pain, morning stiffness and the like, but also suffer from the bad emotions of anxiety, depression and the like due to joint dysfunction, limited activity and the like, and the great pains in both physical and psychological aspects seriously affect the life quality of the patients. The goal of clinical treatment of RA is to reduce or eliminate the symptoms of inflammation, delay and control the progression of joint bone destruction, and avoid joint dysfunction or loss. However, some patients with RA have serious illness and have no obvious effect after being treated by non-steroidal anti-inflammatory drugs or small-dose glucocorticoids. The large dose of glucocorticoid treatment has obvious anti-inflammatory effect, but the rebound phenomenon can occur when the glucocorticoid is stopped suddenly, and adverse reactions such as opportunistic infection, aseptic osteonecrosis and the like can occur when the glucocorticoid is used for a long time, thus causing more pain to patients. The biological agents newly marketed are expensive, and a large economic burden is hard to bear by most patients. In addition, the etiology and pathogenesis of RA are unknown, no radical treatment method is available, adverse reactions of western medicines are generally concerned, and the traditional Chinese medicine has remarkable advantages in treating RA.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis.
In order to achieve the purpose, the technical scheme of the invention is as follows:
a traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis comprises the following raw materials in parts by weight:
15-45 parts of astragalus root, 15-45 parts of coix seed, 15-45 parts of salvia root, 15-45 parts of fried white peony root,
5-25 parts of codonopsis pilosula, 5-25 parts of poria cocos, 5-25 parts of bighead atractylodes rhizome, 5-25 parts of radix stephaniae tetrandrae,
5-25 parts of cassia twig, 5-25 parts of parasitic loranthus, 4-20 parts of semen brassicae, 4-20 parts of radix clematidis,
2-18 parts of turmeric, 2-10 parts of ground beetle, 2-10 parts of scorpion and 2-10 parts of centipede.
Further, the traditional Chinese medicine formula comprises the following raw materials in parts by weight:
20-40 parts of astragalus root, 20-40 parts of coix seed, 20-40 parts of salvia root, 20-40 parts of fried white peony root,
10-20 parts of codonopsis pilosula, 10-20 parts of poria cocos, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of radix stephaniae tetrandrae,
10-20 parts of cassia twig, 10-20 parts of parasitic loranthus, 6-18 parts of semen brassicae, 6-18 parts of radix clematidis,
5-15 parts of turmeric, 4-8 parts of ground beetle, 4-8 parts of scorpion and 4-8 parts of centipede.
Further, the traditional Chinese medicine formula comprises the following raw materials in parts by weight:
30 parts of astragalus, 30 parts of coix seeds, 30 parts of salvia miltiorrhiza, 30 parts of fried white paeony roots, 15 parts of codonopsis pilosula, 15 parts of poria cocos, 15 parts of bighead atractylodes rhizome, 15 parts of radix stephaniae tetrandrae, 15 parts of cassia twig, 15 parts of parasitic loranthus, 12 parts of semen brassicae, 12 parts of radix clematidis, 10 parts of turmeric, 6 parts of ground beeltle, 6 parts of scorpio and 6 parts of centipedes.
Furthermore, the traditional Chinese medicine formula is directly decocted with water or prepared into powder, pills or capsules according to the proportion.
The nature, taste and efficacy of the raw materials are as follows:
(1) astragalus root: [ PROPERTIES AND FLAVOUR ] Warm and sweet. [ GUIJING ] Lung and spleen meridians. [ EFFECTIVE FUNCTION ] tonify qi, strengthen superficies, support sore and promote granulation. Mainly treats body weakness and spontaneous perspiration, chronic diarrhea, rectocele, uterine prolapse, chronic nephritis, body weakness and edema, chronic ulcer and unhealed sore opening;
(2) coix seed: [ PROPERTIES AND FLAVOUR ] Cold and sweet. [ GUIJING ] spleen, stomach and lung meridians. [ EFFECTIVE ] effects of promoting diuresis, eliminating dampness, eliminating arthralgia, invigorating spleen, relieving diarrhea, clearing heat, and expelling pus. It can be used for treating dysuria, edema, loempe, rheumatism, spasm, early stage of damp-warm syndrome, spleen deficiency diarrhea, pulmonary abscess, and intestinal abscess;
(3) red sage root: [ PROPERTIES AND FLAVOURS ] COLD; it is bitter. [ GUIJING ] Heart and lung meridians. [ EFFECTIVE ] effects of dispelling blood stasis, relieving pain, promoting blood circulation, dredging channels, clearing away heart-fire and relieving restlessness. Can be used for treating menoxenia, amenorrhea, dysmenorrhea, abdominal mass, thoracico-abdominal pain, arthralgia due to heat, pyocutaneous disease, swelling and pain, vexation, and insomnia; hepatosplenomegaly, angina;
(4) parching radix Paeoniae alba: [ PROPERTIES AND FLAVOURS ] WET; pungent and sweet. [ GUIJING ] spleen, liver and kidney meridians. [ EFFECTIVE ] FU-SUPPORTING, ANTIPROPHYLACTIC, AND QU-FENGSHI. Treating lumbago, dizziness, tinnitus, epilepsy, rheumatalgia, and urticaria;
(5) codonopsis pilosula: [ PROPERTIES AND FLAVOURS ] PING; sweet. [ GUIJING ] Lung and spleen meridians. [ EFFECTIVE ] has effects of invigorating spleen, replenishing qi, invigorating spleen, and benefiting lung. Can be used for treating spleen and lung deficiency, short breath, palpitation, anorexia, loose stool, asthma, cough, internal heat, and diabetes;
(6) tuckahoe, poria cocos: [ PROPERTIES AND FLAVOURS ] PING; sweet and bland. [ GUIJING ] Heart channel, lung channel, and spleen channel. [ EFFECTIVE ACTION ] can induce diuresis, remove dampness, invigorate spleen, and calm heart. Can be used for treating edema, oliguria, palpitation due to phlegm and fluid retention, spleen deficiency, anorexia, loose stool, diarrhea, uneasiness, palpitation, and insomnia;
(7) white atractylodes rhizome: [ PROPERTIES AND FLAVOURS ] WET; sweet and bitter. [ GUIJING ] stomach and spleen meridians. [ EFFECTIVE ACTION ] can invigorate spleen, nourish stomach, eliminate dampness, regulate the middle warmer, and prevent miscarriage. Treating spleen and stomach qi deficiency, anorexia, listlessness, qi deficiency, asthenia, diarrhea, phlegm retention, edema, jaundice, damp arthralgia, dysuresia, dizziness, spontaneous perspiration, and threatened abortion;
(8) stephania tetrandra: [ PROPERTIES AND WESTERN ] is cold and bitter. [ GUIJING ] Lung meridian and bladder meridian. [ EFFECTIVE ACTION ] can drain dampness and heat in the middle energizer. Treating edema and tympanites, damp-heat beriberi, limb contracture pain, tinea, scabies and sore swelling;
(9) cassia twig: [ PROPERTIES AND FLAVOUR ] pungent and sweet; and (4) warming. [ GUIJING ] Heart meridian, lung meridian, and bladder meridian. [ EFFECTIVE ACTION ] can induce sweating, dispel muscles, warm meridians, and dredge collaterals. Treating wind-cold exterior syndrome, soreness and pain of shoulder, back and limbs, thoracic obstruction, phlegm retention, amenorrhea and abdominal mass;
(10) parasitic loranthus: [ PROPERTIES AND FLAVOURS ] PING; sweet and bitter. [ GUIJING ] liver and kidney meridians. [ EFFECTIVE ACTION ] can nourish liver and kidney; strengthening bones and muscles; dispelling wind-damp; preventing miscarriage. Soreness of the waist and knees; flaccidity of tendons and bones; partial withering of limbs; rheumatic arthralgia; head error and dizziness; threatened abortion, metrorrhagia and metrostaxis and bleeding;
(11) white mustard seed: [ PROPERTIES AND FLAVOURS ] WET; and (5) pungent. [ GUIJING ] stomach meridian and lung meridian. [ EFFECTIVE ] phlegm-resolving and fluid retention-expelling; dissipate stagnation and relieve swelling. Cough and dyspnea with excessive phlegm; fullness in the chest and hypochondriac pain; numbness of limbs; joint swelling and pain; damp phlegm flowing and injecting; deep rooted carbuncle of yin type with pyogenic infections;
(12) clematis root: [ PROPERTIES AND FLAVOURS ] WET; pungent and salty in flavor. [ GUIJING ] the urinary bladder meridian. [ EFFECTIVE ] can dispel pathogenic wind, remove dampness, dredge collaterals, and relieve pain. Can be used for treating rheumatic arthralgia, numbness of limbs, spasm of tendons and vessels, difficulty in flexion and extension, choking throat;
(13) turmeric: [ PROPERTIES AND WESTERN ] is warm, pungent and bitter. [ GUIJING ] spleen meridian and liver meridian. [ EFFECTIVE ] the actions of breaking blood and moving qi, restoring menstrual flow and alleviating pain. Can be used for treating thoracic and hypochondriac pain, amenorrhea, abdominal mass, rheumatism, shoulder and arm pain, and traumatic injury with swelling and pain;
(14) ground beetle: [ PROPERTIES AND FLAVOUR ] Cold and salty. [ GUIJING ] liver meridian. [ EFFECTIVE ] can break blood stasis and reunite tendons and bones. Can be used for treating fracture of bones and muscles, amenorrhea due to blood stasis, and abdominal mass;
(15) scorpion: [ PROPERTIES AND FLAVOURS ] PING; and (5) pungent. [ GUIJING ] liver meridian. [ EFFECTIVE ] calming endogenous wind, relieving spasm, counteracting toxic pathogen, resolving hard mass, dredging collaterals, and relieving pain. Can be used for treating infantile convulsion, spasm, facial distortion due to apoplexy, hemiplegia, tetanus, rheumatism, headache, pyocutaneous disease, and lymphoid tuberculosis;
(16) centipede: [ PROPERTIES AND FLAVOUR ] WEN, pungent. [ GUIJING ] liver meridian. [ EFFECTIVE ACTION ] can dispel pathogenic wind, arresting convulsion, counteracting toxic substance, and resolving hard mass. It can be used for treating apoplexy, epilepsy, tetanus, pertussis, scrofula, tuberculosis, tumor mass, pyocutaneous disease, tinea, alopecia areata, anal fistula, and scald.
Has the advantages that: the traditional Chinese medicine provided by the invention has definite curative effect, small toxic and side effects and few side effects, treats both principal and secondary aspects of diseases, and has the effects of tonifying qi, activating blood, eliminating phlegm and eliminating arthralgia. In addition, the medicine can be prepared into various dosage forms for convenient taking. The compatibility of the whole formula of the invention embodies a large treatment method of tonifying qi, activating blood, eliminating phlegm and treating arthralgia. The joint is beneficial to improving the symptoms of patients, shortening the course of disease and improving the life quality of the patients by treating both principal and secondary aspects of disease through the Shuli joint. The radix stephaniae tetrandrae and radix astragali decoction of the radix astragali, the rhizoma atractylodis macrocephalae and the radix stephaniae tetrandrae has reasonable formula and refined medication, so that the radix stephaniae tetrandrae and radix astragali decoction is regarded as a representative formula for tonifying qi, promoting diuresis and dispelling wind by virtue of the previous sages; radix Codonopsis has effect in invigorating qi; the coix seeds can promote diuresis and eliminate dampness, clear heat and remove arthralgia to treat red swelling and hot pain of joints, and can also strengthen spleen to protect spleen and stomach, and the white mustard seeds can promote walk, dredge channels and collaterals, are the essential medicines for treating phlegm outside the skin and lining membranes, and can also reduce swelling, dissipate stagnation, dredge collaterals and relieve pain; the salvia miltiorrhiza is added, has the effects of promoting blood circulation and promoting blood circulation, is good at entering blood system, can promote blood circulation, remove stasis and stagnation, remove stasis and promote tissue regeneration, is an essential medicine for treating arthralgia, removes stasis and promotes tissue regeneration without breaking, and has the functions of 'one salvia miltiorrhiza, the medicine and four medicines'; eupolyphaga Seu Steleophaga, Curcuma rhizome, and radix Paeoniae alba have effects of promoting blood circulation and relieving pain. Ramulus Cinnamomi, radix Stephaniae Tetrandrae, and radix Clematidis have the effects of dredging channels and collaterals, dispelling pathogenic wind, removing dampness, dredging collaterals, relieving pain, and dredging channels and collaterals. Scorpion and centipede, being pungent and warm, are good at dredging collaterals and relieving pain, attacking toxin and dissipating stagnation, and treating rheumatism stubborn paralysis, are mutually combined to strengthen the effects of removing collaterals and eliminating pathogenic factors. The compatibility of the cassia twig and the white peony root is the specific application of the traditional Chinese medicine in regulating ying and wei and yin and yang.
Detailed Description
The invention is illustrated below with reference to specific examples. It will be understood by those skilled in the art that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention in any way.
Example 1
A traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis comprises the following raw materials: 30g of astragalus, 30g of coix seeds, 30g of salvia miltiorrhiza, 30g of fried white paeony roots, 15g of codonopsis pilosula, 15g of poria cocos, 15g of bighead atractylodes rhizome, 15g of radix stephaniae tetrandrae, 15g of cassia twig, 15g of parasitic loranthus, 12g of semen brassicae, 12g of radix clematidis, 10g of turmeric, 6g of ground beetles, 6g of scorpios and 6g of centipedes. Decocting in water 450ml, 3 times daily, 150ml each time. Or making into powder, pill or capsule at a certain proportion, 3 times daily, 10 parts of effective Chinese medicinal components each time.
Clinical observations
1. Clinical data:
the patients with the rheumatoid arthritis of qi deficiency, blood stasis and phlegm stagnation type who participate in the clinical test have 54 cases, 26 cases for men and 28 cases for women; maximum age 78 years, minimum age 40 years, average age 62 years. The study adopts random grouping, takes example 1 as an experimental group and takes diclofenac sodium sustained-release tablets as a control group.
2. Symptom discrimination:
the evaluation table of the clinical symptom efficacy of the patients with rheumatoid arthritis of qi deficiency, blood stasis and phlegm stagnation type in this example is formulated according to the "standard of efficacy for diagnosis of traditional Chinese medicine symptoms".
3. The clinical test method comprises the following steps:
the traditional Chinese medicine formula in the example 1 is adopted, one dose of 450ml is decocted in water every day, and 150ml is taken in three times in the morning, at noon and at night. Two courses of treatment (one month per course of treatment) were observed. Clinical tests are carried out according to the clinical research guiding principle of the new traditional Chinese medicine for treating the arthralgia.
4. The results of the treatment are shown in Table 1
TABLE 1 therapeutic results
| Group name | Number of examples | Show effect | Is effective | Invalidation | Significant efficiency% | The total effective rate% |
| Experimental group | 27 | 18 | 7 | 2 | 66.6 | 92.5 |
| Control group | 27 | 13 | 8 | 6 | 48.1 | 77.7 |
The effective and ineffective effects of the group name cases are more effective than the total effective rate%
Experimental group 27187266.692.5
Control group 27138648.177.7
The total effective rate of the experimental group is 92.5%, the significant efficiency is 66.6%, and compared with the control group, the curative effect of the experimental group is better than that of the control group.
5. Typical cases
Case 1: in certain plum, women are 56 years old, the symptoms are manifested as aching and pain of joints and muscles, and the activities are not free, thus seriously affecting daily life. After the traditional Chinese medicine formula is orally taken for 15 days, the symptoms are gradually relieved, and after the traditional Chinese medicine formula is continuously taken for 35 days, the symptoms are relieved, and the joints move freely.
Case 2: in case of a certain king, male, age 62, the symptoms of bilateral knee joint pain are more than four years, activity is limited, and pain is aggravated when walking and squatting. Infusion, oral administration of Chinese and western medicines, local closure and other methods for treatment are more and more serious, but no obvious effect is seen. After the traditional Chinese medicine formula is orally taken for 30 days, the symptoms are gradually relieved, and the symptoms are relieved after the traditional Chinese medicine formula is continuously taken for 30 days without pain and relapse.
Claims (4)
1. The traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis is characterized by comprising the following raw materials in parts by weight:
15-45 parts of astragalus root, 15-45 parts of coix seed, 15-45 parts of salvia root, 15-45 parts of fried white peony root,
5-25 parts of codonopsis pilosula, 5-25 parts of poria cocos, 5-25 parts of bighead atractylodes rhizome, 5-25 parts of radix stephaniae tetrandrae,
5-25 parts of cassia twig, 5-25 parts of parasitic loranthus, 4-20 parts of semen brassicae, 4-20 parts of radix clematidis,
2-18 parts of turmeric, 2-10 parts of ground beetle, 2-10 parts of scorpion and 2-10 parts of centipede.
2. The traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis according to claim 1, wherein the traditional Chinese medicine formula comprises the following raw materials in parts by weight:
20-40 parts of astragalus root, 20-40 parts of coix seed, 20-40 parts of salvia root, 20-40 parts of fried white peony root,
10-20 parts of codonopsis pilosula, 10-20 parts of poria cocos, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of radix stephaniae tetrandrae,
10-20 parts of cassia twig, 10-20 parts of parasitic loranthus, 6-18 parts of semen brassicae, 6-18 parts of radix clematidis,
5-15 parts of turmeric, 4-8 parts of ground beetle, 4-8 parts of scorpion and 4-8 parts of centipede.
3. The traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis according to claim 1, wherein the traditional Chinese medicine formula comprises the following raw materials in parts by weight:
30 parts of astragalus, 30 parts of coix seeds, 30 parts of salvia miltiorrhiza, 30 parts of fried white paeony roots, 15 parts of codonopsis pilosula, 15 parts of poria cocos, 15 parts of bighead atractylodes rhizome, 15 parts of radix stephaniae tetrandrae, 15 parts of cassia twig, 15 parts of parasitic loranthus, 12 parts of semen brassicae, 12 parts of radix clematidis, 10 parts of turmeric, 6 parts of ground beeltle, 6 parts of scorpio and 6 parts of centipedes.
4. The traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis according to claim 1, wherein the traditional Chinese medicine formula is directly decocted with water or prepared into powder, pills or capsules according to a proportion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111144369.6A CN113633745A (en) | 2021-09-28 | 2021-09-28 | Traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111144369.6A CN113633745A (en) | 2021-09-28 | 2021-09-28 | Traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113633745A true CN113633745A (en) | 2021-11-12 |
Family
ID=78426385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111144369.6A Withdrawn CN113633745A (en) | 2021-09-28 | 2021-09-28 | Traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113633745A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367911A (en) * | 2014-10-13 | 2015-02-25 | 深圳市前海安测信息技术有限公司 | Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof |
-
2021
- 2021-09-28 CN CN202111144369.6A patent/CN113633745A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367911A (en) * | 2014-10-13 | 2015-02-25 | 深圳市前海安测信息技术有限公司 | Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104958484A (en) | traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction and preparing method of traditional Chinese medicine unguent | |
| CN106265999A (en) | A kind of treat cervical spondylosis, the pill medicine of lumbar spondylosis and preparation method | |
| CN103479819B (en) | The Chinese prescription of traditional Chinese medicine fumigating moxibustion therapy treatment rheumatoid arthritis | |
| CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN106177639A (en) | One treats psoriatic Chinese medicine composition and preparation method thereof | |
| CN113633745A (en) | Traditional Chinese medicine formula for treating qi deficiency, blood stasis and phlegm stagnation type rheumatoid arthritis | |
| CN103536671B (en) | Drug for treating ischialgia | |
| CN106692817A (en) | Ointment medicine for treating eczematous dermatitis and preparation method thereof | |
| CN106266636A (en) | A kind of new medicine compositions treating arthralgia and preparation method | |
| CN106511905A (en) | Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof | |
| CN112717096A (en) | Chinese herbal medicine foot bath powder capable of reducing uric acid and dissipating wind and tonifying kidney | |
| CN105663897A (en) | Traditional Chinese medicine composition for treating zoster | |
| CN104740036A (en) | Traditional Chinese medicine composition for treating Qi stagnation and blood stasis amenorrhea | |
| CN109620944B (en) | A Chinese medicinal composition with effects of dispelling pathogenic wind, removing dampness, strengthening tendons and bones, and its preparation method | |
| CN103585589A (en) | Medicine for treating chronic rheumatoid arthritis | |
| CN103550615A (en) | Traditional Chinese medicine for treating spleen-kidney deficiency scouring disease | |
| CN103127258A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN105688075A (en) | Novel oral preparation for treating stomachache and preparation method thereof | |
| CN104815017A (en) | Traditional Chinese medicine ointment for treating osteoproliferation and preparation method of ointment | |
| CN104740405A (en) | Traditional Chinese medicine preparation for treating anaphylactoid purpura renal damage and preparation method for traditional Chinese medicine preparation | |
| CN113952445A (en) | Traditional Chinese medicine formula for treating malignant lymphoma | |
| CN110960581A (en) | Pain-relieving pill | |
| CN116920064A (en) | Traditional Chinese medicine formula for treating rheumatic bone diseases and processing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20211112 |
|
| WW01 | Invention patent application withdrawn after publication |